Vectors based on Adenovirus type 5 (Ad5) are among the most common vectors in cancer gene therapy trials to date. However, for increased efficiency and safety, Ad5 should be de-targeted from its native receptors and re-targeted to a tumor antigen. We have described earlier an Ad5 vector genetically re-targeted to the tumor antigen HER2/neu by a dimeric version of the Affibody molecule ZH inserted in the HI-loop of the fiber knob of a coxsackie and adenovirus receptor-binding ablated fiber. This virus showed almost wild-type growth characteristics and infected cells through HER2/neu. Here we generate vectors with double specificity by incorporating two different Affibody molecules, ZH (HER2/ neu-binding) and ZT (Taq polymerase-binding), at different positions relative to one another in the HI-loop. Receptorbinding studies together with viral production and gene transfer assays showed that the recombinant fiber with ZT in the first position and ZH in the second position (ZTZH) bound to both its targets, whereas surprisingly, the fiber with ZHZT was devoid of binding to HER2/neu. Hence, it is possible to construct a recombinant adenovirus with dual specificity after evaluating the best position for each ligand in the fiber knob.
Introduction
Human adenoviruses (Ad) are widely used as cancer gene therapy vectors both for clinical trials and experimental purposes. The reasons for this are that adenovirus vectors can accommodate relatively large transgenes, easy to grow to high titers, can efficiently transfer genes to both dividing and nondividing cells and are biologically safe compared with other vectors. 1 In contrast, the coxsackie and adenovirus receptor (CAR), which is the most common receptor for adenovirus, is often downregulated in tumor cells. 2, 3 Furthermore, when treating tumor diseases by gene therapy a high degree of specificity of virus entrance is necessary to avoid side effects from virus entry into normal cells. To overcome these hurdles the adenovirus vector needs to be retargeted to new cellular receptors and de-targeted from binding to normal healthy tissues. Re-targeting can be achieved by the use of bi-specific reagents, chemical coupling of ligands to the virion or by genetic fusion of a suitable ligand with viral capsid proteins. [4] [5] [6] However, new ligands to be incorporated genetically into Ad vectors must be able to fold correctly in the reducing environment of the mammalian cell cytoplasm. This excludes most ligands dependent on disulfide bond formation for proper folding such as epidermal growth factor and most single chain variable fragments. 7 Earlier we have shown that Affibody molecules, which are affinity proteins based on a 58-amino-acid three-helix bundle structure termed Z, that are derived from the Igbinding domain of staphylococcal protein A 8, 9 can be efficiently used for genetic re-targeting of Ad. 10 Phage display libraries have been constructed, based on randomization of 13 surface accessible amino acids in the Z domain, from which novel Affibody molecules to desired targets have been selected. 9, 11 The choice of anchoring capsid protein, for incorporation of new ligands, of the adenovirus vector is of great importance, as manipulation of capsid proteins may negatively affect the virus phenotype. It has, for instance, been showed that knobless Ads with a new cell-binding ligand and an external trimerization motif on truncated fibers are difficult to produce to wild-type (WT) titers and exhibit poor growth characteristics. 7 The fiber knob has to be maintained for efficient virus production and the HI-loop has been identified as the best position for ligand incorporation compared with viral hexon and pIX. [12] [13] [14] We have presented earlier an Ad type 5 (Ad5) vector genetically re-targeted with the HER2/neu-specific Affibody molecule ZH, flanked by linkers, inserted in the HI-loop of the fiber knob of a CAR-binding ablated fiber. The linkers were constructed to provide extra flexibility and allow independent folding for both the affinity protein and the knob domain. The virus showed almost WT growth characteristics and did infect cells through the new cellular receptor in vitro.
In this study the aim was to construct a re-targeted adenovirus fiber with two different Affibody molecules to achieve double specificity and to evaluate the binding specificities for the Affibody molecules inserted in tandem in different positions relative to one another, in the HI-loop of the fiber knob. The Affibody molecules were fused head-to-tail using the same linkers as in the CAR-binding ablated fiber described above. 15 The Affibody molecules used here were ZH and ZT. ZH binds to the extracellular domain of the epidermal growth factor receptor 2 (HER2/neu, also called ErbB2), which is associated with increased cell proliferation and decreased apoptotic capacity in breast cancer cells. [16] [17] [18] ZT binds to taq polymerase and also to the 'anti-idiotypic' Affibody molecule Zztaq. 19, 20 ZT has no biological significance and is used only to investigate the model. Receptor-binding experiments together with viral production and gene transfer assays showed that it was possible to generate recombinant adenoviruses with double specificity. The results also showed the importance of evaluating the relative positions of the affinity proteins within the HI-loop of the fiber knob, as, surprisingly, one of the recombinant fibers only bound to one of the two targets.
Results

Construction of recombinant fiber proteins
The objective of this study was to produce adenovirus vectors with dual specificity using the Affibody molecules ZH and ZT binding to HER2/neu and taq polymerase, respectively. ZH has been used earlier for targeting of Ad when inserted as a dimer into the HIloop flanked by flexible linkers. 15 Thus, the same concept was used here but with two different affinity proteins. To produce a functional double-targeted virus, the position of the different Affibody molecules within the HI-loop of the Ad fiber knob had to be evaluated. To achieve this, fibers with ZH in the first position followed by ZT (designated ZHZT) and the reverse (designated ZTZH) were produced and compared with recombinant fibers with ZH as a monomer or dimer in the HI-loop and to the WT fiber. Schematic figures of the recombinant fiber proteins used in this study are shown in Figure 1 . The gene encoding ZH was inserted in the HI-loop as a monomer (Figure 1b) or dimer ( Figure 1c ) and in the first position followed by the Affibody molecule ZT (Figure  1d ) or in the second position after ZT (Figure 1e ) of a CAR-binding ablated fiber. The fibers were named FibWT, FibZH, FibZHZH, FibZHZT and FibZTZH. FibZH and FibZHZH correspond to FibDCARHI-link-ZH and FibDCARHI-link-ZHZH and have been published earlier. 15 To name recombinant viruses, the prefix Ad5 was added.
Phenotypic analysis of recombinant fiber proteins
To analyze the properties of recombinant fibers and compare them with the WT-fiber, all fibers were expressed in insect cells using baculovirus vectors. Recombinant fiber proteins were assayed according to the following criteria: (i) solubility, (ii) trimerization and (iii) ligand reactivity to cellular receptors. Re-targeted adenovirus vectors with dual specificity S Myhre et al Solubility. We have shown earlier that solubility of recombinant fibers expressed in the cytoplasm of Sf9 cells is a reliable criteria for correct folding and ability to yield viable and functional viruses. 7 The solubility status was tested by denatured SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting of infected Sf9 cell lysates where the total (t), insoluble (is) and soluble (s) fractions were compared. All recombinant fibers had close to equal solubility as compared with WTfiber (data not shown).
Trimerization. The trimerization status was studied by western blot analysis of fiber samples electrophoresed in nondenaturing SDS-PAGE (NDS-PAGE). 7 The NDS-PAGE pattern of the WT-fiber showed a strong band for the trimer and a weaker band for the monomer (Figure 2 , lane 5). A similar pattern was observed for all four recombinant fibers tested: FibZH, FibZHZH, FibZHZT and FibZTZH, all of which were able to form trimers ( Figure 2, lanes 1-4) 20 The cell binding of the recombinant fibers was detected by the antibody 4D2.5 reactive with the fiber tail and a fluorescein isothiocyanate (FITC)-labeled antimouse antibody. As expected the WT fiber was found to bind all three cell types ( Figure 3 
Generation of recombinant virus
After establishing fibers with double specificity, the WT fiber gene was replaced by the recombinant fibers FibZHZT and FibZTZH in the Ad5 genome using homologous recombination and cosmid cloning. 21 Both viruses were constructed to express green fluorescent protein (GFP) in E1 for detection of transduction. Ad5/ FibZHZT and Ad5/FibZTZH genomes were transfected to 293 Zztaq cells and 293 HER2/neu cells. For Ad5/FibZTZH, GFP plaques were visible 7 days post transfection and virus could be produced on both cell lines. In contrast, for Ad5/FibZHZT, GFP plaques were observed on both cell types after 7 days but the plaques on 293 HER2/neu cells were quite small and few. Virus could be rescued on 293 Zztaq cells, whereas for the 293 HER2/neu cells the virus spread slowly and could be produced only with difficulties. Both Ad5/FibZHZT and Ad5/FibZTZH were produced on 293 Zztaq cells for purification. Ad5/FibZHZH was produced on 293 HER2/neu cells as Re-targeted adenovirus vectors with dual specificity S Myhre et al described earlier and no virus could be rescued and purified with FibZH. 15 
Ratio of physical particles to plaque-forming units
To compare the recombinant viruses with WT, physical particles (PP) per ml and plaque-forming units (PFU) per ml were determined by optical absorbance and end-point dilution, respectively. The PP-to-PFU ratio was 680 for Ad5/FibZHZT and 670 for Ad5/FibZTZH when titrated on 293 Zztaq cells, but increases to 11 700 for Ad5/ FibZHZT and 2400 for Ad5/FibZTZH when titrated on 293 HER2/neu cells (Table 1) .
Fiber content
The number of fiber copies per virion for Ad5/FibZHZT, Ad5/FibZTZH, Ad5/FibZHZH and Ad5/FibWT were compared in cesium chloride (CsCl)-purified virus samples (Table 1) . Equal numbers of physical particles were analyzed and probed for penton base and fiber tail. Protein analysis showed that when the amount of penton base was normalized, the Ad5/FibZHZT and Ad5/ FibZTZH had fiber contents of 25% as compared with Ad5/FibWT ( Figure 4 ). Ad5/FibZHZH has also been reported earlier to have a fiber content of approximately 25%. 15 
Growth rate of recombinant virus
The growth rate of Ad5/FibZHZT and Ad5/FibZTZH was determined by measurement of the infectious progeny yields (titered by plaque assays on 293 Zztaq cells) and compared with Ad5/FibWT ( Figure 5a ). The growth curves of the Ad5/FibZHZT and Ad5/FibZTZH viruses suggest that they were slower in production of infectious particles compared with Ad5/FibWT. At 48 h post infection the recombinant viruses reached a steady state and at 72 h the difference in production of viral plaque-forming particles were approximately one-and-ahalf log lower than Ad5/FibWT. To further establish the production yields at different time points, we studied the DNA and protein production (Figures 5b and c). Results showed that both the DNA replication and protein production (here showed for hexon, 100K and penton base) of the recombinants are in the same range as WT (Figures 5b and c) . The physical particle yield at 48-72 h post infection is also displayed in Table 1 .
Cellular specificity of recombinant viruses
To determine if the infectivity pattern of the recombinant viruses correlated with the fiber binding and transfection results, we studied gene transfer and expression of GFP to 293, 293 HER2/neu and 293 Zztaq cells ( Figure 6 Figure 7 ). No blocking of the viruses was observed when adding free knob indicating that the CAR-binding site was removed and there was no The ratio between PP and PFU was determined by optical absorbance and end-point dilution on 293 Zztaq cells, respectively. e The ratio between PP and PFU was determined by optical absorbance and end-point dilution on 293 HER2/neu cells, respectively. 9 PP of CsCl-purified Ad virions were analyzed by SDS-PAGE and western blot using a-penton base and a-fiber tail antibodies followed by AP-conjugated anti-rabbit or anti-mouse antibodies, respectively. Measurements of fiber loads were made by the ImageJ program. PP, physical particles; Ad, adenoviruses; AP, alkaline phosphate.
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Finally, we made an infection experiment on the breast cancer cell line BT474 to assess a possible transduction difference in a cell line naturally expressing HER2/neu. As shown in Figure 8 Ad5/FibZTZH transduced 33% of the cells, whereas Ad5/FibZHZT only transduced 22%, showing the same positional effects. Re
Discussion
The results presented here show that it is possible to genetically incorporate the sequence of two different Affibody molecules into the HI-loop of the fiber knob and retain the cell-binding specificity for both affinity proteins. At the same time it is shown that, surprisingly, the relative order between the two Affibody molecules could have a significant impact on their ability to bind to their respective cellular receptor. The Affibody molecules used here were ZH, which binds to the tumor antigen HER2/neu that is a highly relevant ligand for cancer gene therapy purposes and ZT, which binds to taq polymerase that is a ligand used only to establish the model. The ligands, surrounded by flexible linkers, were incorporated in the HI-loop of a CAR-binding ablated fiber knob. The reason for choosing the HI-loop of the fiber knob as the genetic fusion partner to the Affibody molecules was that we, in a previous study, have shown that Ad vectors with ligands incorporated in the HI-loop of the fiber knob flanked by linkers are greatly superior in terms of growth characteristics to vectors with deknobbed fibers and vectors with ligands in the HI-loop without linkers. 15 It was also shown that the virus with a tandem-repeat version of ZH in the HI-loop (Ad5/ FibZHZH) had much better growth and binding properties compared with the virus with ZH incorporated as a monomer. We have not assayed whether ZH binds to HER2/neu at both positions in FibZHZH. However, realtime biospecific interaction analysis using Biacore indicated that both fiber constructs (with ZH incorporated as a monomer or as a dimer) did bind to HER2/neu in the same nM range (unpublished result), suggesting that there is a possibility that only one of the two Affibody molecules in FibZHZH is capable of binding to the receptor. The reason for the superiority of ZHZH over ZH is therefore not clear, but is probably not imposed by the binding of ZH to HER2/neu per se as the two constructs exhibited roughly the same binding affinity to HER2/neu. Instead, it could be that the tandem repeat for some reason imposes less negative influence on the flanking knob sequence than the monomer.
After producing the viruses, we studied the PP-to-PFU ratio, which was 680 for Ad5/FibZHZT and 670 for Ad5/ FibZTZH when titrated on 293 Zztaq cells and was approximately fivefold higher compared with the ratio for Ad5/FibZHZH titrated on 293 HER2/neu cells. On the other hand, the ratio was improved in contrast to an Ad5 virus containing the knobless fiber R7-ZHZH, which was found to have PP-to-PFU ratio of 40 000 (unpublished results). However, the PP-to-PFU ratio for Ad5/ FibZHZT and for Ad5/FibZTZH was 11 700 and 2400, respectively when titrated on 293 HER2/neu cells. The high PP-to-PFU ratio for Ad5/FibZHZT may also indicate a weak binding and infectivity for this virus through ZH.
To further characterise the virus yield and quality, the virus growth and fiber content was analyzed. As the growth curve reviled about one log less PFU per cell as compared with WT at 72 h post infection, we studied the DNA-replication yields and protein production at each time point. Judged by the results, the lower PFU per cell yield could not be explained by hampered production of the different Ad components. However, the fiber content study showed that on average only 3 out of 12 fiber positions of the virions are occupied. Most likely, this can have an impact on the amount of functional particles produced per cell.
The results presented here, showing that the recombinant fiber FibZHZT did not bind to HER2/neu expressing cells, correlated with the results from virus generation, where Ad5/FibZHZT could be produced on cells expressing the Zztaq receptor and only with difficulties on cells expressing HER2/neu. However, some virus production could be achieved resulting in a very high PP-to-PFU ratio of approximately 11 700. In Re-targeted adenovirus vectors with dual specificity S Myhre et al contrast, Ad5/FibZTZH could be rescued on cells expressing either receptor. The results also correlated to the gene transfer assay, where Ad5/FibZHZT showed much higher transduction of 293 Zztaq cells compared with 293 HER2/neu and BT474 cells. Ad5/FibZTZH, however, transduced all three cell lines to the same extent. It was somewhat unexpected that Ad5/FibZTZH transduced 293 Her2/neu cells to a higher degree compared with Ad5/FibZHZH, considering that the PP-to-PFU ratio for Ad5/FibZHZH is lower than for Ad5/FibZTZH. This virus also showed a somewhat higher transduction to 293 cells compared with the other recombinant viruses, and the competition assay only inhibited transduction to 35-55% of control. This could be due to an unspecific binding that is independent of the ZT-Zztaq interaction. This type of binding that is independent of fiber knob/ cellular receptor binding but leading to transduction is important to consider and evaluate when constructing recombinant viruses with new specificities.
The lack of binding of ZH to HER2/neu when incorporated in the first relative position in the HI-loop and evaluated by fiber binding was unexpected and the reason unclear. To exclude mutations or recombinations resulting in a nonfunctional or nonexistent ZH motif, the fiber of Ad5/FibZHZT was sequenced and shown to be intact. The next issue to consider was misfolding, but it is not likely that misfolding of the Affibody molecule is involved considering the very stable folding of these molecules. 9 Furthermore, the flexible linkers should provide freedom for the Affibody molecule to move and bind to its epitope. However, the results show that the relative position of the Affibody molecules is crucial for binding and that the outcome of binding of two Affibody molecules incorporated as a tandem repeat according to the technology employed here can at present not be predicted. Therefore, it is necessary to evaluate all novel fibers with dual tropism for their cellbinding specificities before generating recombinant viruses. It should also be noted that even though the FibZHZH showed specificity for 293 HER2/neu cells and FibZHZT for 293 Zztaq cells, when evaluated for fiber binding, the specificity of virus cell transduction was not as clear. A low degree of transduction was seen to 293 Zztaq cells for Ad5/FibZHZH and to 293 HER2/neu cells for Ad5/FibZHZT, but this was less than one-fifth compared with control cells. The transduction of Ad5/ FibZHZH to 293 Zztaq cells could be due to a theoretical cross reactivity between the anti-idiotypic Affibody molecule Zztaq and ZH, and the transduction of Ad5/ FibZHZT to 293 HER2/neu cells indicates a weak binding between ZH and HER2/neu that was not seen in the fiber-binding assay or some other type of binding not accounted for using the technologies employed here. In the inhibition assay, none of the recombinant viruses were completely blocked by adding free ZH or ZT, which may be due to a dynamic competition between the virus and the Affibody molecule at 37 1C or to other interactions between the virus and host cells. It has also been shown earlier that ZH Affibodies are internalized over time at 37 1C, which makes it possible for the virus to bind the liberated receptor and infect the cell. 22 Earlier attempts to incorporate two different Affibody molecules into the same fiber were made using knobless fibers and even though it was shown that both Affibody molecules could bind to their respective target, the virus suffered from low fiber content and infectivity. 10 Others have also showed double targeting by placing one ligand in the HI-loop and the other at the C-terminus of the fiber protein. [23] [24] [25] These studies were limited to incorporation of shorter peptide ligands and were mainly used to enhance Ad5 infectivity.
The new technology to generate Ad vectors with double specificity gives rise to several possibilities. A virus could for instance be constructed to target (i) two different therapeutic cellular receptors, thereby minimizing the chance that cells with downregulated receptor expression could escape being hit by the virus, (ii) one tumor-specific receptor and a receptor found on stroma cells within the tumor or (iii) one tumor receptor and a neo-endothelial antigen for an aided passage into the tumor from the blood stream. It remains to be shown whether it is possible to incorporate three or more Affibody molecules in the HI-loop of the fiber knob to achieve an Ad vector with even more targeting options.
Materials and methods
Cells
HEK-293 cells (abbreviated as 293 cells) were purchased from Microbix (Toronto, Ontario, Canada), 293 HER2/neu cells are 293 cells stably transfected to express surfacebound HER2/neu 15 and 293 Zztaq cells are 293 cells stably transfected to express membrane-bound Zztaq. Zztaq is an anti-idiotypic Affibody molecule, which has been selected to bind to ZT. 20 293, 293 HER/2neu and 293 Zztaq cells were grown in Iscove's medium (Gibco BRL, Invitrogen Life Technologies, Groningen, The Netherlands) supplemented with 10% fetal bovine serum (Sigma-Aldrich, Stockholm, Sweden) and 50 mg ml À1 gentamycin (Gibco BRL) and maintained at 37 1C and 5% CO 2 . BT474 cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and grown in Modified Dulbecco's medium (Hybri-care, ATCC) with the same supplements and culture conditions as above.
Spodoptera frugiperda Sf9 cells were purchased from the ATCC. Sf9 cells were grown in TC100 medium (Gibco BRL) with the above mentioned supplements at 28 1C.
Immuno reagents
Mouse monoclonal antibody 4D2.5 (anti-Ad5 fiber tail) 26 was kindly provided by Dr Jeffery Engler (University of Alabama, Birmingham, AL, USA). Anti-CAR antibody was produced from the RmcB mouse myeloma cell line from ATCC (CRL-2379). Rabbit anti-penton base and a rabbit polyclonal against penton base, 100K and hexon (AdV-poly) were kindly provided by Professor Pierre Boulanger (University Claude Bernard de Lyon, Lyon, France). FITC-conjugated anti-mouse IgG rabbit F(ab) 2 (F0313) and FITC-conjugated rabbit anti-human IgG (F0315) were purchased from DAKO (Glostrup, Denmark). Alkaline phosphate (AP)-conjugated goat antimouse IgG (A3563), AP-conjugated goat anti-rabbit IgG (A3812) and FITC-conjugated albumin (A7016) were purchased from Sigma-Aldrich. Anti-HER2/neu Herceptin (humanized mIgG1) was from Roche (Basel, Switzerland).
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Targeting ligands
Affibody molecules are based on the non-cystein threehelix bundle structure of a modified staphylococcal protein A domain termed Z. 8, 9 Through combinatorial protein engineering targeted to surface located residues of the Z domain, libraries have been constructed from which novel variants have been selected. 9, 11 The Affibody molecules used in this study are the ZH, specific for the extra cellular domain of human epidermal growth factor receptor 2, 17 the ZT, which binds taq polymerase 19 and the anti-idiotypic Affibody molecule Zztaq. 20 The Affibody molecules were expressed as His 6 -tagged fusion proteins in Escherichia coli strain BL21(DE3) and purified with immobilized metal ion affinity chromatography. 27 The purity and correct molecular mass of the proteins were analyzed using SDS-PAGE gel and high-performance liquid chromatography-mass spectrography.
Generation of CAR-ablated fibers carrying the Affibody molecules ZH, ZHZH, ZHZT and ZTZH in the HI-loop of the fiber knob
The construction of FibZH and FibZHZH has been described earlier. 15 Recombinant fibers FibZTZH and FibZHZT were constructed in a similar way. Briefly, the sequence CCATCGATC containing a ClaI restriction site was inserted into the HI-loop of the Ad5 WT fiber between the GGA (amino acid G541) and the GAC (amino acid D542) using splicing by overlap extension. Ablation of the CAR-binding site was constructed through deletion of residues Leu 485 and Thr 486 corresponding to the b-strand in the fiber knob. 28 Linkers containing the amino acids Gly and Ser were introduced on either side of the Affibody molecule and the following adapter was ligated into the ClaI site described above CGATCGGTTCTGGTGGTGGTTCTAGAGGATCCGGCG GCTCCGGTGGTCCAT. The adapter contains XbaI and BamHI sites (underlined) for ligation of Affibody molecule sequences. The corresponding restriction sites were introduced into ZH and ZT by PCR. Splicing by overlap extension was used to create a fusion gene with a flexible (G 4 S) 2 linker between the ZH and ZT domain (GGCGGCGGTGGTTCTGGTGGTGGCGGCTCC).
Phenotypic analysis of fiber proteins
Ad5 WT fiber and recombinant fibers were cloned into the pBacPak9 vector (Clontech, Palo Alto, CA, USA). Recombinant baculoviruses (Autographa californica Nuclear Polyhedrosis Virus) were generated by homologous recombination in Sf9 cells using the BacVector-1000 DNA Kit, as described by the manufacturer (Novagen, Madison, WI, USA). Fiber proteins were expressed in Sf9 cells infected with recombinant baculoviruses and analyzed according to the following criteria: (i) solubility, (ii) trimerization and (iii) ligand reactivity by cellular binding. The methods have been described in detail earlier. 7, 15 Briefly, fiber expressing baculovirus-infected Sf9 cells were harvested 48 h post infection, lysed in hypotonic buffer (10 mM Tris-HCl buffer, pH 7.5) at 0 1C, adjusted to isotonic conditions (150 mM NaCl in10 mM Tris-HCl buffer, pH 7.5) and centrifuged at 10 000 g, 4 1C, for 10 min. For solubility assay the fraction of soluble fiber in the supernatant was compared with the insoluble fraction in the pellet and to the total fiber content after analysis by western blot. For trimerisation assays the soluble fraction was analyzed as boiled or unboiled samples on nondenaturing SDS-PAGE followed by western blot. For the cell-binding assay the fiber-containing supernatants were applied to cells in suspension (293, 293 HER2/neu and 293 Zztaq cells) prewashed in phosphate-buffered saline (0.01 M phosphate, 0.15 M NaCl). After washing the cells they were incubated with antibody 4D2.5 and washed in phosphate-buffered saline, followed by incubation with FITC-conjugated rabbit anti-mouse Igs. Negative controls with supernatants from uninfected Sf9 cells were performed. FITClabeled cells were analyzed using fluorescent-activated cell sorter (FACSsort, Becton Dickinson, Heidelberg, Germany) as described earlier. 7 Cell surface expression of HER2/neu, CAR and Zztaq was analyzed by staining the cells as described above but using 10 mg ml À1 Herceptin, RmcB-anti-CAR or ZTalbumin-binding domain antibody followed by FITClabeled anti-human IgG, anti-mouse IgG or albumin (Sigma-Aldrich), respectively.
Rescue of recombinant fibers into virions
The Ad5/WT fiber gene was replaced by the FibZTZH and FibZHZT fibers, respectively, in the Ad5 genome, using an earlier described procedure based on homologous recombination and cosmid cloning. 21 Generation of Ad5/FibZH and Ad5/FibZHZH viruses have been described earlier; 15 however, Ad5/FibZH could not be produced to high titers and was not further evaluated. In the resulting recombinant Ad5 genome, the E1 region was replaced with the GFP gene under a cytomegalovirus promoter. PCR amplification verified the presence of a correct fiber insert. The cosmid was also controlled by cleavage with HindIII and SpeI. Recombinant Ad5 genomes were restricted with PacI and used to transfect 293 HER2/neu and 293 Zztaq cells using the FuGeneHD technology according to the manufacturer's protocol (Roche). The occurrence of plaques was determined by microscopic inspection of the transfected cell cultures. Presence of viruses was verified by PCR and GFP expression. Viruses were purified from 293 Zztaq -infected cells by freeze thawing followed by CsCl gradient. All virus stocks were titered on 293 Zztaq and 293 HER2/neu cells by end-point dilution, and the titer expressed as PFU per ml 29 and the number of viral particles per milliliter was determined by optical absorbance. 30 
Fiber content of recombinant Ad5 virions
The fiber copy number of CsCl-purified Ad5 virions was determined using SDS-PAGE and western blot analysis. Blots were reacted with anti-tail mouse monoclonal antibody 4D2.5 followed by AP-conjugated anti-mouse IgG or rabbit anti-penton base polyclonal Ab followed by mouse anti-rabbit AP to assay the fiber versus penton content. Quantification was performed comparing the amount of fibers in Ad5/ FibZHZT and Ad5/FibZTZH viruses to known amount of fibers in Ad5/FibWT (100%) and Ad5/FibZHZH (25%) viruses. 15 
Growth rate of recombinant Ad
Growth rate was measured by the production of PFU in infected cells. 293 Zztaq cells were infected with 800 PP per cell of Ad5/FibZHZT, Ad5/FibZTZH or Ad5/FibWT at Re-targeted adenovirus vectors with dual specificity S Myhre et al 37 1C in Iscove's medium. After 2 h the cells were washed and 1 ml complete medium (Iscove's medium with 10% FBS and 50 mg/ml gentamycin) was added. Cells and medium was harvested 25, 48 and 72 h post infection. After cell lysis by freeze thawing, the number of infectious virions in the lysates was determined on 293 Zztaq cells by end-point dilution, and the recombinant virus yield was expressed as PFU per GFP-expressing infected cell. The Ad protein content (hexon, 100K and penton base) at different time points was tested from the growth curve samples by SDS-PAGE followed by western blot. The blot was reacted with a polyclonal rabbit antibody (AdV-poly) followed by mouse antirabbit AP. The replication rate of the Ad genome was studied in the growth curve samples using real-time PCR (RT-PCR). DNA from each sample was purified using QIAamp DNA Kit (Qiagen, Solna, Swden) and analyzed by RT-PCR with primers in the fiber tail (R Fi and F Fi ). For quantification, the circular Ad5 plasmid, used to produce Ad5/FibWT, was used to make a standard curve.
Quantitative PCR
RT-PCR was carried out using Power SYBR Green (Applied Biosystems, Warrington, UK) in an Applied Biosystems 7500 real-time PCR system detector. PCR primers R tail (reverse primer 5 0 -TGCCGCCGCACCTCT AAT-3 0 ) and F tail (forward primer 5 0 -GTCCTTGGGTGGC AATGCTAA-3 0 ) were designed using the Primer Express software (Applied Biosystems). A final reaction volume of 20 ml consisted of 10 ml Power SYBR Green PCR Master Mix (Applied Biosystems), 1 ml of each primer, 2 ml sample and 6 ml H 2 O. All samples were amplified in triplicates under the following conditions: 95 1C for 10 min and 40 cycles of 95 1C for 15 s and 60 1C for 1 min.
Gene transfer assay
The re-targeting of Ad5/FibZHZH, Ad5/FibZHZT and Ad5/FibZTZH was studied by gene transfer of GFP to different cell types. Infections were performed in 24-well plates for 2 h at 37 1C in 200 ml Iscove's medium. After infection, cells were washed once in medium and kept in Iscove's medium supplemented with 10% fetal bovine serum and 50 mg ml À1 gentamycin, over night at 37 1C. After approximately 24 h, the cells were harvested, fixed in 1.5% paraformaldehyde for 15 min and washed with phosphate-buffered saline. GFP-expressing cells were counted using fluorescent-activated cell sorter (FACSsort, Becton Dickinson) as described earlier. 21 Blocking was performed by adding 200 mg ml À1 (ZH) 2 (fused to the albumin-binding domain for purification), 200 mg ml À1 (ZT) 2 or 200 mg ml À1 of both (ZH) 2 and (ZT) 2 to the cells for 1 h at 4 1C after which the virus was added and the incubation continued at 37 1C for 2 h. After infection, cells were washed once in complete Iscove's medium and kept in medium with the same supplements overnight at 37 1C. After approximately 15-20 h, the cells were harvested, fixed with 0.5% glutaraldehyde for 1 h and washed with phosphatebuffered saline. GFP-expressing cells were counted using fluorescent-activated cell sorter (FACSsort, Becton Dickinson) as described earlier. 7 
